Prelude Therapeutics Incorporated (PRLD) Earnings
NASDAQ·Healthcare·Biotechnology
$4.64
-0.64%
Mkt Cap $310.85M
EPS — Estimate vs Actual
Mkt Cap
$310.85M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58
NASDAQ·Healthcare·Biotechnology
$4.64
-0.64%
Mkt Cap $310.85M
Mkt Cap
$310.85M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58